QTERN is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Astrazeneca Pharmaceuticals Lp. The primary component is Dapagliflozin; Saxagliptin Hydrochloride.
Product ID | 0310-6770_49e0634f-e72d-4c07-8336-d197048e78ba |
NDC | 0310-6770 |
Product Type | Human Prescription Drug |
Proprietary Name | QTERN |
Generic Name | Dapagliflozin And Saxagliptin |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2017-12-04 |
Marketing Category | NDA / NDA |
Application Number | NDA209091 |
Labeler Name | AstraZeneca Pharmaceuticals LP |
Substance Name | DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE |
Active Ingredient Strength | 5 mg/1; mg/1 |
Pharm Classes | Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2019-06-17 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA209091 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-06-17 |
Marketing Category | NDA |
Application Number | NDA209091 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-07-01 |
Ingredient | Strength |
---|---|
DAPAGLIFLOZIN | 5 mg/1 |
SPL SET ID: | 423c489c-085b-4320-b892-7868ebd6dc6b |
Manufacturer | |
UNII | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0310-6770 | QTERN | dapagliflozin and saxagliptin |
0310-6780 | QTERN | dapagliflozin and saxagliptin |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
QTERN 86344649 4816032 Live/Registered |
AstraZeneca AB 2014-07-22 |